Adjuvant PD-1 antibody in recurrent, previously irradiated oral cavity cancer treated with salvage surgeryShengjin Dou, Guopei Zhu, Wen Jiang et al.|Clinical and Translational Radiation Oncology|2023Cited by 2
Postoperative Radiotherapy with Docetaxel Versus Cisplatin for High-Risk Oral Squamous Cell Carcinoma: A Randomized Phase II Trial with Exploratory Analysis of ITGB1 as a Potential Predictive BiomarkerWen Jiang, Shuyang Sun, Yanli Yao et al.|SSRN Electronic Journal|2023Cited by 1